Expansion of HIV-specific T follicular helper cells in chronic HIV infection

Journal of Clinical Investigation

Volumn 122, Issue 9, 2012, Pages 3271-3280

  Lindqvist, Madelene ^a   Van Lunzen, Jan ^b   Soghoian, Damien Z ^a   Kuhl, Bjorn D ^a   Ranasinghe, Srinika ^a   Kranias, Gregory ^a   Flanders, Michael D ^a   Cutler, Samuel ^a   Yudanin, Naomi ^c   Muller, Matthias I ^a   Davis, Isaiah ^a   Farber, Donna ^c   Hartjen, Philip ^b   Haag, Friedrich ^b   Alter, Galit ^a   Zur Wiesch, Julian Schulze ^b   Streeck, Hendrik ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c NewYork Presbyterian Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; GAMMA INTERFERON; GLYCOPROTEIN GP 120; IMMUNOGLOBULIN G1; INTERLEUKIN 21; PROGRAMMED DEATH 1 RECEPTOR; PROTEIN BCL 6; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL EXPANSION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; GERMINAL CENTER; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN PRODUCTION; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; T FOLLICULAR HELPER CELL; VIREMIA; VIRUS LOAD;

ANTI-RETROVIRAL AGENTS; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CELL PROLIFERATION; CELLS, CULTURED; CHRONIC DISEASE; DNA-BINDING PROTEINS; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNOGLOBULIN G; INTERLEUKINS; LYMPH NODES; RECEPTORS, CXCR5; T-LYMPHOCYTES, HELPER-INDUCER; VIREMIA;

EID: 84865997747     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI64314     Document Type: Article

References (51)

1. Moir S, Fauci AS. B cells in HIV infection and disease. Nat Rev Immunol. 2009;9(4):235-245.
2. Titanji K, et al. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS. 2005;19(17):1947-1955. (Pubitemid 41669018)
3. Malaspina A, et al. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci U S A. 2006;103(7):2262-2267. (Pubitemid 43271658)
4. De Milito A, et al. Mechanisms of hypergammaglobulinemia and impaired antigenspecific humoral immunity in HIV-1 infection. Blood. 2004;103(6):2180- 2186. (Pubitemid 38326236)
5. Schnittman SM, Lane HC, Higgins SE, Folks T, Fauci AS. Direct polyclonal activation of human B lymphocytes by the acquired immune deficiency syndrome virus. Science. 1986;233(4768):1084-1086. (Pubitemid 16032239)
6. Lefevre EA, Krzysiek R, Loret EP, Galanaud P, Richard Y. Cutting edge: HIV-1 Tat protein differentially modulates the B cell response of naive, memory, and germinal center B cells. J Immunol. 1999;163(3):1119-1122. (Pubitemid 29352724)
7. Qiao X, He B, Chiu A, Knowles DM, Chadburn A, Cerutti A. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat Immunol. 2006;7(3):302-310.
8. Popovic M, et al. Persistence of HIV-1 structural proteins and glycoproteins in lymph nodes of patients under highly active antiretroviral therapy. Proc Natl Acad Sci U S A. 2005;102(41):14807-14812. (Pubitemid 41457137)
9. Moir S, et al. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J Exp Med. 2000;192(5):637-646.
10. Morris L, et al. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med. 1998;188(2):233-245. (Pubitemid 28357752)
11. Mattapallil JJ, Douek DC, Hill B, Nishimura Y, Martin M, Roederer M. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature.2005;434(7037):1093-1097. (Pubitemid 40663481)
12. McHeyzer-Williams M, Okitsu S, Wang N, McHeyzer-Williams L. Molecular programming of B cell memory. Nat Rev Immunol. 2012;12(1):24-34.
13. Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621-663.
14. Yu D, et al. The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity. 2009;31(3):457-468.
15. Baumjohann D, Okada T, Ansel KM. Cutting Edge: Distinct waves of BCL6 expression during T follicular helper cell development. J Immunol. 2011;187(5):2089-2092.
16. Simpson N, et al. Expansion of circulating T cells resembling follicular helper T cells is a fixed phenotype that identifies a subset of severe systemic lupus erythematosus. Arthritis Rheum. 2010;62(1):234-244.
17. Kroenke MA, et al. Bcl6 and Maf cooperate to instruct human follicular helper CD4 T cell differentiation. J Immunol. 2012;188(8):3734-3744.
18. Chtanova T, et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol. 2004;173(1):68-78. (Pubitemid 38797327)
19. Kuchen S, et al. Essential role of IL-21 in B cell activation, expansion, and plasma cell generation during CD4+ T cell-B cell collaboration. J Immunol. 2007;179(9):5886-5896.
20. Bussmann BM, Reiche S, Bieniek B, Krznaric I, Ackermann F, Jassoy C. Loss of HIV-specific memory B-cells as a potential mechanism for the dysfunction of the humoral immune response against HIV. Virology. 2010;397(1):7-13.
21. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol. 2005;5(10):783-792. (Pubitemid 41400852)
22. Tenner-Racz K, et al. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. J Exp Med. 1998;187(6):949-959. (Pubitemid 28141668)
23. Sette A, et al. Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities. Immunity. 2008;28(6):847-858. (Pubitemid 351778408)
24. Klasse PJ, Sanders RW, Cerutti A, Moore JP. How can HIV-type-1-Env immunogenicity be improved to facilitate antibody-based vaccine development? AIDS Res Hum Retroviruses. 2012;28(1):1-15.
25. Binley JM, et al. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J Virol. 1997;71(4):2799-2809. (Pubitemid 27119919)
26. Li Y, et al. Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals. J Virol. 2009;83(2):1045-1059.
27. Binley JM, et al. Profiling the specificity of neutralizing antibodies in a large panel of plasmas from patients chronically infected with human immunodeficiency virus type 1 subtypes B and C. J Virol. 2008;82(23):11651- 11668.
28. Moore PL, Gray ES, Morris L. Specificity of the autologous neutralizing antibody response. Curr Opin HIV AIDS. 2009;4(5):358-363.
29. Muller F, Froland SS, Brandtzaeg P. Altered IgG-subclass distribution in lymph node cells and serum of adults infected with human immunodeficiency virus (HIV). Clin Exp Immunol. 1989;78(2):153-158. (Pubitemid 20009835)
30. Aucouturier P, et al. Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome. Clin Exp Immunol. 1986;63(1):234-240. (Pubitemid 16196425)
31. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD. Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med. 1994;180(1):329-339. (Pubitemid 24181081)
32. Cappione A 3rd, et al. Germinal center exclusion of autoreactive B cells is defective in human systemic lupus erythematosus. J Clin Invest. 2005;115(11):3205-3216.
33. Fahey LM, Wilson EB, Elsaesser H, Fistonich CD, McGavern DB, Brooks DG. Viral persistence redirects CD4 T cell differentiation toward T follicular helper cells. J Exp Med. 2011;208(5):987-999.
34. Fazilleau N, McHeyzer-Williams LJ, Rosen H, McHeyzer-Williams MG. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol. 2009;10(4):375-384.
35. Douek DC, et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature. 2002;417(6884):95-98. (Pubitemid 34498823)
36. Petrovas C, et al. CD4 T follicular helper cell dynamics during SIV infection. J Clin Invest. 2012;122(9):3281-3294.
37. Ozaki K, et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol. 2004;173(9):5361-5371. (Pubitemid 39392119)
38. Linterman MA, et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med. 2010;207(2):353-363.
39. Linterman MA, et al. Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med. 2011;17(8):975-982.
40. Chung Y, et al. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions. Nat Med. 2011;17(8):983-988.
41. Malaspina A, et al. Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood. 2007;109(5):2086-2088. (Pubitemid 46348209)
42. Ettinger R, et al. IL-21 induces differentiation of human naive and memory B cells into antibodysecreting plasma cells. J Immunol.2005;175(12):7867- 7879. (Pubitemid 41798347)
43. Bryant VL, et al. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol. 2007;179(12):8180-8190.
44. Shacklett BL. Mucosal immunity to HIV: a review of recent literature. Curr Opin HIV AIDS. 2008;3(5):541-547.
45. Brenchley JM, et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med. 2004;200(6):749-759. (Pubitemid 39299461)
46. Doria-Rose NA, et al. Breadth of human immunodeficiency virus-specific neutralizing activity in sera: clustering analysis and association with clinical variables. J Virol. 2010;84(3):1631-1636.
47. Zhou T, et al. Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science. 2010;329(5993):811-817.
48. Pancera M, et al. Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternaryspecific antibodies that effectively neutralize HIV-1. J Virol. 2010;84(16):8098-8110.
49. Soghoian DZ, et al. HIV-specific cytolytic CD4 T cell responses during acute HIV infection predict disease outcome. Sci Transl Med. 2012;4(123):123ra125.
50. Chevalier MF, et al. HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function. J Virol. 2011;85(2):733-741.
51. Vlug A, Nieuwenhuys EJ, van Eijk RV, Geertzen HG, van Houte AJ. Nephelometric measurements of human IgG subclasses and their reference ranges. Ann Biol Clin (Paris). 1994;52(7-8):561-567. (Pubitemid 24338810)